The Administrative Core oversees all functions of the DHC, including membership, delivery of Core Services, the Enrichment Program, monitoring of the scientific output of Center investigators, administration of the Pilot and Feasibility Program, and budget. The day-to-day operation is the responsibility of the Center Director (Dr. Jorge Bezerra) and of the Project Manager (Dr. Cynthia Wetzel). The Director, Project Manager, and the Associate Directors [Drs. Mitchell Cohen, Marshall (Chip) Montrose, and Aaron Zorn] form the Leadership Committee and meet every Thursday to review any issues related to Core utilization and progress in major functions of the Center (Enrichment Program, Pilot and Feasibility Program, Clinical Component). This weekly meeting, which was implemented at the start of the DHC four years ago, greatly facilitates communication among the leadership and enables the Project Manager to respond to the needs of the DHC membership in a timely fashion. The primary appointment of two investigators from outside the GI Division Dr. Montrose (Cell Physiology, University of Cincinnati College of Medicine-UCCOM) and Dr. Zorn (Development Biology, Cincinnati Children's Hospital Medical Center-CCHMC), further enhances the exchange of knowledge within the leadership of programmatic initiatives taking place in the Academic Health Center (CCHMC and UCCOM), thus enabling the DHC leadership to take advantage of these initiatives to create opportunities to better serve the DHC membership and the field of digestive disease research. The Leadership Committee is the main component of the Administrative Core;its relationship to the Internal and External Advisory Boards, CCHMC and the Academic Health Center will be presented later in this section.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK078392-06
Application #
8334758
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (J1))
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$551,779
Indirect Cost
$191,139
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Li, Jun; Razumilava, Nataliya; Gores, Gregory J et al. (2014) Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 124:3241-51
Kulkarni, Rishikesh M; Stuart, William D; Waltz, Susan E (2014) Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia. Hepatobiliary Pancreat Dis Int 13:281-92
Haberman, Yael; Tickle, Timothy L; Dexheimer, Phillip J et al. (2014) Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 124:3617-33
Kopec, Anna K; Joshi, Nikita; Towery, Keara L et al. (2014) Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. J Pharmacol Exp Ther 351:288-97
Zhao, H; Chen, M-S; Lo, Y-H et al. (2014) The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene 33:1429-37
Suzuki, Takuji; Arumugam, Paritha; Sakagami, Takuro et al. (2014) Pulmonary macrophage transplantation therapy. Nature 514:450-4
Fulkerson, Patricia C; Schollaert, Kaila L; Bouffi, Carine et al. (2014) IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation. J Immunol 193:4043-52
Kulkarni, Rishikesh M; Stuart, William D; Gurusamy, Devikala et al. (2014) Ron receptor signaling is protective against DSS-induced colitis in mice. Am J Physiol Gastrointest Liver Physiol 306:G1065-74
Mehta, Minesh; Slaughter, Crystal; Xanthakos, Stavra A et al. (2014) High prevalence of hepatitis B non-immunity in paediatric non-alcoholic fatty liver disease patients. Dig Liver Dis 46:760-1
Aihara, Eitaro; Closson, Chet; Matthis, Andrea L et al. (2014) Motility and chemotaxis mediate the preferential colonization of gastric injury sites by Helicobacter pylori. PLoS Pathog 10:e1004275

Showing the most recent 10 out of 156 publications